Evidence map›Paper›PMID 22492519›Full record

Trial reportStroke2012

Baseline cardiovascular risk predicts subsequent changes in resting brain function.

Lori L Beason-Held, Madhav Thambisetty, Gerard Deib, Jitka Sojkova, Bennett A Landman, Alan B Zonderman, Luigi Ferrucci, Michael A Kraut, Susan M Resnick

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Stroke, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.The Journal of clinical endocrinology and metabolism · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Type 2 diabetes and cognitive impairment: contributions from neuroimaging.Journal of geriatric psychiatry and neurology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lori L Beason-HeldIntramural Research Program, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. heldlo@mail.nih.gov
Madhav Thambisetty
Gerard Deib
Jitka Sojkova
Bennett A Landman
Alan B Zonderman
Luigi Ferrucci
Michael A Kraut
Susan M Resnick
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

The Baltimore Longitudinal Study Of AgingZIAAG000015 · NIA · NATIONAL INSTITUTE ON AGING · PI SIMONSICK, ELEANOR MARIE · 2009 to 2025
$116.9M
Neuroimaging Predictors of Cognitive Decline, Impairment, and ResilienceZIAAG000191 · NIA · NATIONAL INSTITUTE ON AGING · PI FERRUCCI, LUIGI · 2009 to 2025
$26.4M
Understanding mechanisms and seeking novel biomarkers in Alzheimer's diseaseZIAAG000200 · NIA · NATIONAL INSTITUTE ON AGING · PI RESNICK, SUSAN · 2013 to 2024
$12.2M
NEUROIMAGING PREDICTORS OF COGNITIVE CHANGE AND RESPONSE TO THERAPYZ01AG000191 · NIA · NATIONAL INSTITUTE ON AGING · PI RESNICK, SUSAN M · 1997 to 2008
$1.9M
EARLY MARKERS OF ALZHEIMERS DISEASEN01AG032124 · NIA · JOHNS HOPKINS UNIVERSITY · PI BRYAN, R N · 1993 to 1999
–
Intramural NIH HHS Z01 AG000191NIA NIH HHS N01-AG-3-2124
6 · The paper itself

Abstract

background and purposeThe Framingham Heart Study group cardiovascular disease risk profile (FCRP) score was used to assess the relationship between baseline cardiovascular risk and subsequent changes in resting state cerebral blood flow (CBF) in cognitively normal older participants from the Baltimore Longitudinal Study of Aging.

methodsNinty-seven cognitively normal participants underwent annual resting-state positron emission tomography scans at baseline and over a period of up to 8 years (mean interval, 7.4 years). Images quantifying voxel-wise longitudinal rates of CBF change were calculated and used to examine the relationship between baseline FCRP score and changes over time in regional CBF. Individual components of the FCRP score (age, cholesterol, blood pressure, smoking status, and type 2 diabetes) were also correlated with changes in regional CBF to examine the independent contributions of each component to the overall pattern of change.

resultsHigher baseline FCRP scores were associated with accelerated longitudinal decline in CBF in orbitofrontal, medial frontal/anterior cingulate, insular, precuneus, and brain stem regions. Of the components that comprise the FCRP score, higher diastolic blood pressure and diabetes were associated independently with greater decline in the medial frontal/anterior cingulate and insular regions, respectively.

conclusionsBaseline cardiovascular risk factors are associated with greater rates of decline in resting state regional brain function. The regions showing accelerated decline participate in higher-order cognitive processes and are also vulnerable to age-related neuropathology. These results, in conjunction with other studies, encourage early treatment of cardiovascular risk factors in older individuals.

Indexed as

AgingCerebrovascular CirculationAgedAged, 80 and overBrainCardiovascular DiseasesFemaleHumansLongitudinal StudiesMiddle AgedPositron-Emission TomographyRisk Factors

Identifiers

PMID22492519
PMCPMC3361601
OpenAlexW2025377726

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.